State Street’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $137M | Sell |
|
|||||
2023
Q3 | $120M | Buy |
|
|||||
2023
Q2 | $93.3M | Buy |
|
|||||
2023
Q1 | $85.9M | Sell |
|
|||||
2022
Q4 | $115M | Buy |
|
|||||
2022
Q3 | $110M | Sell |
|
|||||
2022
Q2 | $126M | Buy |
|
|||||
2022
Q1 | $117M | Buy |
|
|||||
2021
Q4 | $152M | Buy |
|
|||||
2021
Q3 | $162M | Buy |
|
|||||
2021
Q2 | $136M | Sell |
|
|||||
2021
Q1 | $181M | Sell |
|
|||||
2020
Q4 | $236M | Sell |
|
|||||
2020
Q3 | $181M | Sell |
|
|||||
2020
Q2 | $141M | Sell |
|
|||||
2020
Q1 | $97.8M | Buy |
|
|||||
2019
Q4 | $159M | Sell |
|
|||||
2019
Q3 | $103M | Buy |
|
|||||
2019
Q2 | $118M | Sell |
|
|||||
2019
Q1 | $104M | Sell |
|
|||||
2018
Q4 | $65M | Buy |
|
|||||
2018
Q3 | $66.1M | Buy |
|
|||||
2018
Q2 | $48.1M | Buy |
|
|||||
2018
Q1 | $21.4M | Sell |
|
|||||
2017
Q4 | $13M | Buy |
|
|||||
2017
Q3 | $356K | Buy |
|
|||||
2017
Q2 | $49K | Sell |
|
|||||
2017
Q1 | $1.11M | Buy |
|
|||||
2016
Q4 | $905K | Buy |
|
|||||
2016
Q3 | $1.12M | Buy |
|
|||||
2016
Q2 | $917K | Sell |
|
|||||
2016
Q1 | $7.5M | Sell |
|
|||||
2015
Q4 | $11.7M | Buy |
|
|||||
2015
Q3 | $4.91M | Buy |
|
|||||
2015
Q2 | $3.71M | Buy |
|
|||||
2015
Q1 | $2.63M | Buy |
|
|||||
2014
Q4 | $1.24M | Buy |
|
|||||
2014
Q3 | $1.12M | Buy |
|
|||||
2014
Q2 | $1.16M | Buy |
|